Skip to main content
Top
Published in: Osteoporosis International 7/2008

01-07-2008 | Letter

Comment on Tothill and Hannan: precision and accuracy of measuring changes in bone mineral density by dual-energy X-ray absorptiometry

Authors: G. Phillipov, C. J. Seaborn

Published in: Osteoporosis International | Issue 7/2008

Login to get access

Excerpt

Dear Editors, …
Literature
3.
go back to reference Li Z, Chines AA, Meredith MP (2004) Statistical validation of surrogate endpoints: is bone density a valid surrogate for fracture? J Musculoskelet Neuronal Interact 4:64–74PubMed Li Z, Chines AA, Meredith MP (2004) Statistical validation of surrogate endpoints: is bone density a valid surrogate for fracture? J Musculoskelet Neuronal Interact 4:64–74PubMed
5.
go back to reference Wu Y, Chesler DA, Glimcher MJ et al (1999) Multinuclear solid-state three-dimensional MRI of bone and synthetic calcium phosphates. PNAS 96:1574–1578PubMedCrossRef Wu Y, Chesler DA, Glimcher MJ et al (1999) Multinuclear solid-state three-dimensional MRI of bone and synthetic calcium phosphates. PNAS 96:1574–1578PubMedCrossRef
6.
go back to reference Lu Y, Ye K, Mathur AK, Hui S, Fuerst TP, Genant HK (1997) Comparative calibration without a gold standard. Stat Med 16:1889–1905PubMedCrossRef Lu Y, Ye K, Mathur AK, Hui S, Fuerst TP, Genant HK (1997) Comparative calibration without a gold standard. Stat Med 16:1889–1905PubMedCrossRef
7.
go back to reference Nielsen SP (2000) The fallacy of BMD: a critical review of the diagnostic use of dual X-ray absorptiometry. Clin Rheumatol 19:174–183PubMedCrossRef Nielsen SP (2000) The fallacy of BMD: a critical review of the diagnostic use of dual X-ray absorptiometry. Clin Rheumatol 19:174–183PubMedCrossRef
8.
go back to reference Bolotin HH (2007) DXA in vivo BMD methodology: an erroneous and misleading research and clinical gauge of bone mineral status, bone fragility, and bone remodelling. Bone 41:138–154PubMedCrossRef Bolotin HH (2007) DXA in vivo BMD methodology: an erroneous and misleading research and clinical gauge of bone mineral status, bone fragility, and bone remodelling. Bone 41:138–154PubMedCrossRef
9.
go back to reference Blake GM, Lewiecki EM, Kendler DL, Fogelman I (2007) A review of strontium ranelate and its effect on DXA scans. J Clin Densitom 10:113–119PubMedCrossRef Blake GM, Lewiecki EM, Kendler DL, Fogelman I (2007) A review of strontium ranelate and its effect on DXA scans. J Clin Densitom 10:113–119PubMedCrossRef
10.
go back to reference Wren TA, Kim PS, Janicka A, Sanchez M, Gilsanz V (2007) Timing of peak bone mass: discrepancies between CT and DXA. J Clin Endocrinol Metab 92:938–941PubMedCrossRef Wren TA, Kim PS, Janicka A, Sanchez M, Gilsanz V (2007) Timing of peak bone mass: discrepancies between CT and DXA. J Clin Endocrinol Metab 92:938–941PubMedCrossRef
11.
go back to reference Zuckerman-Levin N, Yaniv I, Schwartz T, Guttmann H, Hochberg Z (2007) Normal DXA bone mineral density but frail cortical bone in Turner’s syndrome. Clin Endocrinol (Oxf) 67:60–64CrossRef Zuckerman-Levin N, Yaniv I, Schwartz T, Guttmann H, Hochberg Z (2007) Normal DXA bone mineral density but frail cortical bone in Turner’s syndrome. Clin Endocrinol (Oxf) 67:60–64CrossRef
12.
go back to reference Phillipov G, Seaborn CJ, Phillips PJ (2001) Reproducibility of DXA: potential impact on serial measurements and misclassification of osteoporosis. Osteoporos Int 12:49–54PubMedCrossRef Phillipov G, Seaborn CJ, Phillips PJ (2001) Reproducibility of DXA: potential impact on serial measurements and misclassification of osteoporosis. Osteoporos Int 12:49–54PubMedCrossRef
13.
go back to reference Cummings SR, Palermo L, Browner W et al (2000) Monitoring osteoporosis therapy with bone densitometry: misleading changes and regression to the mean. Fracture Intervention Trial Research Group. JAMA 283:1318–1321PubMedCrossRef Cummings SR, Palermo L, Browner W et al (2000) Monitoring osteoporosis therapy with bone densitometry: misleading changes and regression to the mean. Fracture Intervention Trial Research Group. JAMA 283:1318–1321PubMedCrossRef
14.
go back to reference Bonnick SL (2000) Monitoring osteoporosis therapy with bone densitometry: a vital tool or regression toward mediocrity? J Clin Endocrinol Metab 85:3493–3495PubMedCrossRef Bonnick SL (2000) Monitoring osteoporosis therapy with bone densitometry: a vital tool or regression toward mediocrity? J Clin Endocrinol Metab 85:3493–3495PubMedCrossRef
15.
go back to reference Lenchik L, Watts NB (2001) Regression to the mean: what does it mean? Using bone density results to monitor treatment of osteoporosis. J Clin Densitom 4:1–4PubMedCrossRef Lenchik L, Watts NB (2001) Regression to the mean: what does it mean? Using bone density results to monitor treatment of osteoporosis. J Clin Densitom 4:1–4PubMedCrossRef
16.
go back to reference Barnett AG, van der Pols JC, Dobson AJ (2005) Regression to the mean: what it is and how to deal with it. Int J Epidemiol 34:215–220PubMedCrossRef Barnett AG, van der Pols JC, Dobson AJ (2005) Regression to the mean: what it is and how to deal with it. Int J Epidemiol 34:215–220PubMedCrossRef
Metadata
Title
Comment on Tothill and Hannan: precision and accuracy of measuring changes in bone mineral density by dual-energy X-ray absorptiometry
Authors
G. Phillipov
C. J. Seaborn
Publication date
01-07-2008
Publisher
Springer-Verlag
Published in
Osteoporosis International / Issue 7/2008
Print ISSN: 0937-941X
Electronic ISSN: 1433-2965
DOI
https://doi.org/10.1007/s00198-007-0551-5

Other articles of this Issue 7/2008

Osteoporosis International 7/2008 Go to the issue